Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction

By 4 June 2019ASPIRIN RESISTANCE
Platelet-function-abnormalities-in-response-to-arachidonic

Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction

Published on 18th May 2013
Platelet-function-abnormalities-in-response-to-arachidonic

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
896

Joseph S R de Saram CISSP provides thought-provoking insights into Military Intelligence and Law Enforcement, how they operate beyond (as opposed to above) the law, and how their various antics foreseeably lead to the destruction of Fundamental Human Rights. Updates are in progress so check back regularly – verified articles end with . Please feel free to LIKE and SHARE

20130518_000000 JDSSG Borderline ECG Abnormal R and T-waves Dr Victor Lim Parkway Hospital

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

We determined the prevalence and clinical predictors of aspirin resistance by prospectively studying 325 patients with stable cardiovascular disease who were receiving aspirin (325 mg/day for ≥7 days) but no other antiplatelet agents. We also compared the detection of aspirin resistance

Hedding

Enter more text here

Platelet-function-abnormalities-in-response-to-arachidonic

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
RHODIUM GROUP